LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • Wedbush Is Cutting Take-Two Interactive Software Inc (TTWO) FY25 Rev. Estimate To 6.51 Billion From 7.01 Billion 4/17/2024 12:03:42 PM
  • Wedbush Is Lowering Take-Two Interactive Software Inc (TTWO) Q2 25 Rev. Estimate To 1.60 Billion From 1.80 Billion 4/17/2024 12:03:24 PM
  • Wedbush Is Lowering Take-Two Interactive Software Inc (TTWO) Q1 25 Rev. Estimate To 1.25 Billion From 1.55 Billion 4/17/2024 12:03:13 PM
  • Wedbush Is Cutting Take-Two Interactive Software Inc (TTWO) FY24 Rev. Estimate To 5.29 Billion From 5.31 Billion 4/17/2024 12:02:59 PM
  • Wedbush Is Lowering Take-Two Interactive Software Inc (TTWO) Q4 24 Rev. Estimate To 1.30 Billion From 1.33 Billion 4/17/2024 12:02:43 PM
  • Wedbush Is Cutting Take-Two Interactive Software Inc (TTWO) FY25 Estimate To 5.50 From 7.00 4/17/2024 12:01:07 PM
  • Wedbush Is Cutting Take-Two Interactive Software Inc (TTWO) Q2 25 Estimate To 1.30 From 1.80 4/17/2024 12:00:54 PM
  • Wedbush Is Cutting Take-Two Interactive Software Inc (TTWO) Q1 25 Estimate To 0.10 From 1.10 4/17/2024 12:00:43 PM
  • Wedbush Is Cutting Take-Two Interactive Software Inc (TTWO) FY24 Estimate To 2.28 From 2.30 4/17/2024 12:00:25 PM
  • Wedbush Is Lowering Take-Two Interactive Software Inc (TTWO) Q4 24 Estimate To 0.09 From 0.11 4/17/2024 12:00:08 PM
  • Take-Two Interactive Software Enters Agreement With Embracer Group To Acquire Gearbox Entertainment Company For $460 Mln 3/28/2024 12:14:29 AM
  • Takeda :ADZYNMA Intravenous Injection 1500 Approved In Japan For Congenital Thrombotic Thrombocytopenic Purpura 3/26/2024 8:05:19 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap